Structure and activity of a unique heparin-derived hexasaccharide.

作者: R J Linhardt , K G Rice , Z M Merchant , Y S Kim , D L Lohse

DOI: 10.1016/S0021-9258(18)66890-5

关键词:

摘要: Abstract A hexasaccharide representing a major sequence in porcine mucosal heparin has been enzymatically prepared from heparin. Its structure was determined by an integrated approach using chemical, enzymatic, and spectroscopic methods. Two-dimensional 1H homonuclear COSY, C-H correlation NMR, selective irradiation were used to assign many of the NMR resonances. In addition, new techniques including sulfate determination ion chromatography Fourier transform IR californium plasma desorption mass spectroscopy have applied, resulting unambiguous structural assignment delta IdoAp2S(1----4)-alpha-D-GlcNp2S6S(1----4)-alpha-L-IdoAp++ +(1----4)-alpha-D-GlcNA cp6S-(1----4)-beta-D-GlcAp(1----4)-alpha-D-GlcNp2S3S6S (where IdoA represents 4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid, p pyranose, GlcA represent glucuronic iduronic acid). This contains portion antithrombin III-binding site Kd 4 X 10(-5) M. Unlike other small oligosaccharides, which are specific for coagulation factor Xa, it inhibits both factors IIa Xa equally through III. may unique capacity act primarily cofactor II inhibit thrombin (factor IIa) shows over half heparin's II-mediated anti-factor activity. These studies suggest occurrence contiguous binding sites on III, II.

参考文章(39)
Z M Merchant, Y S Kim, K G Rice, R J Linhardt, Structure of heparin-derived tetrasaccharides Biochemical Journal. ,vol. 229, pp. 369- 377 ,(1985) , 10.1042/BJ2290369
U Lindahl, G Bäckström, L Thunberg, The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. Journal of Biological Chemistry. ,vol. 258, pp. 9826- 9830 ,(1983) , 10.1016/S0021-9258(17)44572-8
M J Griffith, C M Noyes, F C Church, Reactive site peptide structural similarity between heparin cofactor II and antithrombin III. Journal of Biological Chemistry. ,vol. 260, pp. 2218- 2225 ,(1985) , 10.1016/S0021-9258(18)89541-2
U Lindahl, L Thunberg, G Bäckström, J Riesenfeld, K Nordling, I Björk, Extension and structural variability of the antithrombin-binding sequence in heparin. Journal of Biological Chemistry. ,vol. 259, pp. 12368- 12376 ,(1984) , 10.1016/S0021-9258(18)90755-6
V C Yang, R J Linhardt, H Bernstein, C L Cooney, R Langer, Purification and characterization of heparinase from Flavobacterium heparinum. Journal of Biological Chemistry. ,vol. 260, pp. 1849- 1857 ,(1985) , 10.1016/S0021-9258(18)89671-5
D M Tollefsen, D W Majerus, M K Blank, Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. Journal of Biological Chemistry. ,vol. 257, pp. 2162- 2169 ,(1982) , 10.1016/S0021-9258(18)34900-7
R J Linhardt, A Grant, C L Cooney, R Langer, Differential anticoagulant activity of heparin fragments prepared using microbial heparinase. Journal of Biological Chemistry. ,vol. 257, pp. 7310- 7313 ,(1982) , 10.1016/S0021-9258(18)34377-1
Vincent C. Hascall, Rick L. Riolo, James Hayward, Clifford C. Reynolds, Treatment of Bovine Nasal Cartilage Proteoglycan with Chondroitinases from Flavobacterium heparinum and Proteus vulgaris Journal of Biological Chemistry. ,vol. 247, pp. 4521- 4528 ,(1972) , 10.1016/S0021-9258(19)45018-7
I Jacobsson, U Lindahl, J W Jensen, L Rodén, H Prihar, D S Feingold, Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. Journal of Biological Chemistry. ,vol. 259, pp. 1056- 1063 ,(1984) , 10.1016/S0021-9258(17)43565-4